LRMR: Volume dana dhuwit perusahaan Larimar Therapeutics

LRMR (Larimar Therapeutics, Inc.) - tandha merek perusahaan

Larimar Therapeutics (LRMR) is developing strategic partnerships with clinics and funds to implement protein therapy. The project portfolio spans various testing phases for treating genetic pathologies, thereby mitigating risks. Resources are currently focused on the commercialization of a key drug. The company's cash dynamics reflect current liquidity levels, with the indicator standing at 0.16.

Sisa dhuwit perusahaan: Larimar Therapeutics Inc (LRMR) kanggo 04.07.2022 - 21.11.2026

Rincian metrik lan analitis perusahaan Larimar Therapeutics, Inc. (LRMR)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:LRMR Larimar Therapeutics
Produk mawa merek larimartx.com

This indicator determines the volume of liquid assets for a real-time assessment of solvency and protection against cash flow gaps. By analyzing the cash history of Larimar Therapeutics (LRMR), an investor can identify the resource base for financing costly neurological research and adhering to strict ESG waste disposal standards. Excess capital reserves may signal inflationary risks; however, sufficient funding confirms operational stability. Current price action demonstrates the issuer's ability to sustain its technological cycle.